356
Participants
Start Date
August 31, 2003
Primary Completion Date
November 30, 2004
Study Completion Date
November 30, 2004
Vernakalant Injection 20 mg/mL
Main Line Health Heart Center, Wynnewood
Medical College of Virginia, Richmond
McGuire VA Medical Center, Richmond
Florida Heart Institute, Orlando
James Haley VA Hospital, Tampa
Thoracic and Cardiovascular Institute, Lansing
Marshfield Clinic, Marshfield
University of California, Los Angeles
Regional Cardiology Associates, Sacramento
Oregon Health & Science University, Portland
Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston
Heart Health Institute, Rockyview General Hospital, Calgary
University of Calgary, Calgary
University of Alberta Hospital, Edmonton
Cardiac Arrhythmia Trials, Victoria
Hamilton Health Sciences, Hamilton General Hospital, Hamilton
Ottawa Hospitals (Civic & General), Ottawa
Sunnybrook Health Sciences Centre, Emergency Medicine Research Program, Toronto
Institut de Cardiologie de Montreal, Montreal
Hopital Notre-Dame du CHUM, Montreal
CHUM-Hotel-Dieu de Montreal, Montreal
Institute de Cardiologie de Quebec, Hopital Laval, Ste Foy
Centre Hospitalier LeGardeur, Terrebonne
Aalborg University, Aalborg
Århus Amtssygehus, Med. kardiologisk, Aarhus
Amager Hospital, Med. Center, Copenhagen
H:S Bispebjerg Hospital, Copenhagen
Helsingor Sygehus, Kardiovaskulært, Elsinore
Centralsygehuset Esbjerg Varde, Esbjerg
Fredericia Sygehus, Fredericia
Frederikssund Sygehus, Frederikssund
Glostrup Amtssygehus, Glostrup Municipality
Haderslev Sygehus, Kardiologisk Laboratorium, Haderslev
Gentofte Amtssygehus, Hellerup
Herlev Amtssygehus, Kardiologisk, Herlev
Hillerod Sygehus, Medicinsk, Hillerød
Sygehus Vendsyssel Hjorring, Hjørring
Holstebro centralsygehus, Holstebro
Horsens Sygehus, Horsens
Hvidovre Hospital, Kardiologisk, Hvidovre
Kolding Sygehus, Kardiologisk ambulatorium, Kolding
Roskilde Amts Sygehus Køge, Køge
Sygehus Fyn Svendborg, Svendborg
Universitetssjukhuset MAS, Malmo
Universitetssjukhuset, Molndal, Mölndal
Universityetssjukhuset, Orebro, Örebro
Danderyds sjukhus, Stockholm
Akademiska Sjukhuset, Uppsala, Uppsala
Centrallasarettet, Vasteras, Västerås
Lead Sponsor
Astellas Pharma US, Inc.
INDUSTRY
Advanz Pharma
INDUSTRY